1. Artificial intelligence is cutting preclinical development timelines from more than three years to under two years. 2. The Food and Drug Administra...

1. After six months, valgus brace users reported a statistically significant and clinically meaningful reduction in knee pain after walking and requir...

1. Midazolam significantly reduces respiratory variability, leading to a more uniform and less adaptable breathing pattern, which may increase risk in...

1. Compared to standard care, measurement-based care resulted in faster time to response and time to remission among adults with major depressive diso...

1. Efruxifermin 50 mg once-weekly significantly improved fibrosis at 96 weeks versus placebo. 2. MASH resolution without worsened fibrosis was greater...

1. Implementing a structured POCUS protocol for inpatients with undifferentiated dyspnea was associated with a 30% reduction in length of stay Evidenc...

Beta blockers ride a pop culture wave into everyday anxiety The Wall Street Journal reported that propranolol prescriptions have increased by nearly 3...

1. The FDA approved rilzabrutinib, branded Wayrilz, as the first BTK (Bruton’s tyrosine kinase) inhibitor for adults with ITP (immune thrombocytopenia...

1. Anderson and colleagues evaluated clinical staff’s response time to patient-sent messages with NLP labelling against that of staff without NLP use....

1. Measurement-based care (MBC) significantly accelerates recovery from major depressive disorder, leading patients to achieve response and remission...